FENC (Fennec Pharmaceuticals) Institutional Ownership: 49.72% (As of Jul. 03, 2026)


FENC Fennec Pharmaceuticals Inc FENC
54 GF Score
Price $10.70
GF Value $10.01
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Fennec Pharmaceuticals Institutional Ownership?

Fennec Pharmaceuticals FENC +3.48% 54 Institutional Ownership is 49.72% as of Jul. 03, 2026. GuruFocus rates FENC with a GF Score™ of 54/100 and a GF Value™ of $10.01 (Fairly Valued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fennec Pharmaceuticals's institutional ownership is 49.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fennec Pharmaceuticals's Insider Ownership is 2.51%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fennec Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 86.29%.

Fennec Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Fennec Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fennec Pharmaceuticals Institutional Ownership Chart

Fennec Pharmaceuticals Historical Data

The historical data trend for Fennec Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 14.79 14.64 12.75 13.07 12.88 13.00 13.16 12.56 12.68 13.12
FENC
54GF Score
Fennec Pharmaceuticals Inc FENC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fennec Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 49.72% mean?
Fennec Pharmaceuticals (FENC) has a Institutional Ownership of 49.72% as of Jul. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Fennec Pharmaceuticals and its competitors.
Is Fennec Pharmaceuticals' Institutional Ownership too high?
Fennec Pharmaceuticals' current Institutional Ownership is 49.72%. Overall, Fennec Pharmaceuticals has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fennec Pharmaceuticals' Institutional Ownership compare to VRTX and REGN?
Fennec Pharmaceuticals' Institutional Ownership of 49.72% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Fennec Pharmaceuticals and its competitors. Fennec Pharmaceuticals's current Institutional Ownership is 49.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fennec Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Fennec Pharmaceuticals (FENC) is currently considered Fairly Valued. The stock's GF Value™ is $10.01, compared to a current price of $10.70 — trading 6.9% above its estimated fair value. The current Institutional Ownership is 49.72%. Fennec Pharmaceuticals' overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Fennec Pharmaceuticals (FENC), the current Institutional Ownership is 49.72% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fennec Pharmaceuticals (FENC) Overvalued in 2026?

Based on GuruFocus' analysis, Fennec Pharmaceuticals stock appears to be overvalued. The current stock price of $10.70 is trading 6.9% above its estimated GF Value™ of $10.01. GuruFocus considers Fennec Pharmaceuticals to be Fairly Valued.

Key valuation signals for FENC:

  • Institutional Ownership: 49.72%
  • GF Value™: $10.01 vs. price of $10.70 (6.9% above fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the FENC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fennec Pharmaceuticals Business Description

Other Exchanges RV41:GermanyFRX:Canada
Address 68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
54GF Score

Get the complete analysis for FENC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.70
Price
$10.01
GF Value